THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

SG Americas Securities, LLC's Holding History (CIK: 0001313360)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 14,509 Value ($000) $0 Avg Close $16.59 Range $13.50 - $20.33

Q3 2025

Shares 6,938 Value ($000) $0 Avg Close $12.64 Range $10.82 - $14.87

Q1 2025

Shares 21,557 Value ($000) $0 Avg Close $9.31 Range $8.35 - $10.90

Q4 2024

Shares 19,202 Value ($000) $0 Avg Close $9.10 Range $7.88 - $10.26

Q3 2024

Shares 15,853 Value ($000) $0 Avg Close $8.66 Range $7.44 - $10.42

Q2 2024

Shares 162,388 Value ($000) $1 Avg Close $9.03 Range $8.13 - $10.44

Q1 2024

Shares 209,566 Value ($000) $2 Avg Close $9.27 Range $8.21 - $11.71

Q4 2023

Shares 197,106 Value ($000) $2 Avg Close $10.06 Range $8.52 - $11.57

Q3 2023

Shares 252,609 Value ($000) $2 Avg Close $9.65 Range $8.25 - $10.59

Q2 2023

Shares 151,134 Value ($000) $2 Avg Close $11.04 Range $9.98 - $12.03

Q1 2023

Shares 30,008 Value ($000) $0 Avg Close $10.57 Range $9.25 - $11.52

Q4 2022

Shares 15,407 Value ($000) $0 Avg Close $10.51 Range $9.56 - $11.83

Q3 2022

Shares 27,265 Value ($000) $276 Avg Close $9.37 Range $7.53 - $11.00

Q2 2022

Shares 17,698 Value ($000) $160 Avg Close $9.21 Range $8.15 - $10.52

Q4 2021

Shares 21,711 Value ($000) $240 Avg Close $8.72 Range $7.30 - $11.24

Q3 2021

Shares 38,968 Value ($000) $288 Avg Close $11.19 Range $6.10 - $15.01

Q2 2021

Shares 8,042 Value ($000) $117 Avg Close $18.78 Range $14.46 - $22.74

Q4 2020

Shares 42,230 Value ($000) $750 Avg Close $17.95 Range $14.48 - $20.53

Q2 2020

Shares 16,643 Value ($000) $349 Avg Close $25.69 Range $20.17 - $31.35

Q1 2020

Shares 28,178 Value ($000) $651 Avg Close $25.03 Range $16.86 - $31.54

Q4 2019

Shares 6,035 Value ($000) $156 Avg Close $19.43 Range $15.72 - $26.47

Q1 2019

Shares 6,890 Value ($000) $156 Avg Close $25.36 Range $21.04 - $28.63

Q1 2018

Shares 5,347 Value ($000) $130 Avg Close $27.46 Range $22.90 - $30.29

Q3 2017

Shares 9,061 Value ($000) $310 Avg Close $32.70 Range $23.15 - $42.61

Q2 2017

Shares 5,931 Value ($000) $236 Avg Close $38.45 Range $34.85 - $43.44

Q1 2017

Shares 5,488 Value ($000) $202 Avg Close $31.95 Range $27.80 - $37.18

Q4 2016

Shares 21,510 Value ($000) $686 Avg Close $31.02 Range $24.54 - $38.92

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	14,509	$0	$16.59	$13.50 - $20.33
Q3 2025	6,938	$0	$12.64	$10.82 - $14.87
Q1 2025	21,557	$0	$9.31	$8.35 - $10.90
Q4 2024	19,202	$0	$9.10	$7.88 - $10.26
Q3 2024	15,853	$0	$8.66	$7.44 - $10.42
Q2 2024	162,388	$1	$9.03	$8.13 - $10.44
Q1 2024	209,566	$2	$9.27	$8.21 - $11.71
Q4 2023	197,106	$2	$10.06	$8.52 - $11.57
Q3 2023	252,609	$2	$9.65	$8.25 - $10.59
Q2 2023	151,134	$2	$11.04	$9.98 - $12.03
Q1 2023	30,008	$0	$10.57	$9.25 - $11.52
Q4 2022	15,407	$0	$10.51	$9.56 - $11.83
Q3 2022	27,265	$276	$9.37	$7.53 - $11.00
Q2 2022	17,698	$160	$9.21	$8.15 - $10.52
Q4 2021	21,711	$240	$8.72	$7.30 - $11.24
Q3 2021	38,968	$288	$11.19	$6.10 - $15.01
Q2 2021	8,042	$117	$18.78	$14.46 - $22.74
Q4 2020	42,230	$750	$17.95	$14.48 - $20.53
Q2 2020	16,643	$349	$25.69	$20.17 - $31.35
Q1 2020	28,178	$651	$25.03	$16.86 - $31.54
Q4 2019	6,035	$156	$19.43	$15.72 - $26.47
Q1 2019	6,890	$156	$25.36	$21.04 - $28.63
Q1 2018	5,347	$130	$27.46	$22.90 - $30.29
Q3 2017	9,061	$310	$32.70	$23.15 - $42.61
Q2 2017	5,931	$236	$38.45	$34.85 - $43.44
Q1 2017	5,488	$202	$31.95	$27.80 - $37.18
Q4 2016	21,510	$686	$31.02	$24.54 - $38.92